Dapatimi M 10mg/500mg Tablet SR
Product Info
Prescription required | Yes |
Marketer | Vishaura Healthcare Private Limited |
Active Ingredient | Dapagliflozin (10mg) + Metformin (500mg) |
Habit Forming | No |
Therapeutic Class | ANTI DIABETIC |
User Rating | 4.4 |
User Reviews | 328 |
FAQ
Dapatimi M 10mg/500mg Tablet SR Reviews
Dapatimi M 10mg/500mg may be taken with food. Take it at the same time every day, this will help you remember to take it. The dose will be decided by your doctor. Don’t stop taking it without asking your doctor. If you do, your blood sugar levels may increase and put you at risk of serious complications like kidney damage and blindness. This medicine is only part of a treatment program that should include a healthy diet, regular exercise, and weight reduction as advised by your doctor.
The most common side effects of this medicine include sore throat, nasal congestion, runny nose, headache, nausea, vomiting, and diarrhea. Drinking plenty of fluids while using it will help prevent dehydration. Some people may develop fungal infections in the genital area. Maintaining good hygiene can help prevent this.
Before taking this medicine, inform your doctor if you have any kidney or liver problems or a urinary tract infection or if you are on water pills (diuretics). Pregnant or breastfeeding women should also consult their doctor before taking it. Avoid excessive alcohol intake while taking it as this may increase the risk of developing some side effects. Monitor your blood sugar levels regularly while taking this medicine.
How Dapatimi M 10mg/500mg Tablet SR Works
How to Use Dapatimi M 10mg/500mg Tablet SR
Benefits of Dapatimi M 10mg/500mg Tablet SR
- In Treatment of Type 2 diabetes mellitus: Dapatimi M 10mg/500mg is a medicine that helps to control high blood glucose (sugar) levels. It helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs. This medicine will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Uses of Dapatimi M 10mg/500mg Tablet SR
- Treatment of Type 2 diabetes mellitus
Dapatimi M 10mg/500mg Tablet SR Side Effects
- Diarrhea
- Decreased creatinine clearance
- Nausea
- Hypoglycemia (low blood glucose level)
- Skin rash
- Increased hematocrit
- Dyslipidemia
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Tremors
- Difficulty in urination
- Urinary tract infection
- Genital fungal infection
- Flatulence
- Taste change
- Vomiting
- Back pain
- Dizziness
- Polyuria
Safety Tips
Quick Tips
- You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines (if prescribed) along with Dapatimi M 10mg/500mg.
- Take it with food to lower your chance of having an upset stomach.
- It may cause your body to lose too much fluid (dehydration) or you to urinate more often. Drink plenty of water and stay hydrated.
- Dapatimi M 10mg/500mg can cause urinary tract infection. Make sure to drink plenty of fluids and practice good genital hygiene.
- Always carry some sugary food or fruit juice with you in case you experience hypoglycemia symptoms such as cold sweats, cool pale skin, tremor, and anxious feeling.
- It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
- It also reduces the risk of heart attack, heart failure or other cardiovascular events.
- You have been prescribed this combination medicine as it can control blood sugar better than metformin alone.
References
- Dapagliflozin and metformin hydrochloride. [Summary of Product Characteristics]. Södertälje, Sweden: AstraZeneca AB; 2021.
- Dapagliflozin + Metformin. Södertälje, Sweden: AstraZeneca; 2014.
- Medscape. Dapagliflozin+Metformin.
- Central Drugs Standard Control Organization. Dapagliflozin+Metformin.
- European Medicine Agency. Xigduo (dapagliflozin / metformin).
- Dapagliflozin and metformin hydrochloride tablets [Product monograph]. Mississauga, Ontario; AstraZeneca Canada Inc.; 2020.
- Dapagliflozin and metformin HCl extended-release. Wilmington, Delaware: AstraZeneca Pharmaceuticals LP; 2014 [revised Jul. 2017].
- Dapagliflozin and metformin [Summary of Product Characteristics]. Södertälje, Sweden: AstraZeneca AB; 2018.